Apple Inc. Declares Quarterly Dividend of $0.17 (NASDAQ:AAPL)

Apple Inc. (NASDAQ:AAPL – Get Rating) announced a quarterly dividend on Tuesday, December 20th, Zacks reports. Shareholders of record on Wednesday, December 28th will be paid a dividend of 0.167 per share by the iPhone maker on Monday, January 9th. This represents a $0.67 dividend on an annualized basis and a dividend yield of 0.50%. The ex-dividend date is Tuesday, December 27th.

Yext, Inc. (NYSE:YEXT) General Counsel Sells $128,200.00 in Stock

Yext, Inc. (NYSE:YEXT – Get Rating) General Counsel Ho Shin sold 20,000 shares of the stock in a transaction that occurred on Tuesday, December 20th. The shares were sold at an average price of $6.41, for a total transaction of $128,200.00. Following the completion of the transaction, the general counsel now directly owns 84,471 shares of the company’s stock, valued at $541,459.11. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Xencor, Inc. (NASDAQ:XNCR) CMO Sells $100,899.00 in Stock

Xencor, Inc. (NASDAQ:XNCR – Get Rating) CMO Allen Yang sold 3,737 shares of the stock in a transaction that occurred on Monday, December 19th. The shares were sold at an average price of $27.00, for a total transaction of $100,899.00. Following the transaction, the chief marketing officer now directly owns 63,521 shares of the company’s stock, valued at $1,715,067. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Sunrun Inc. (NASDAQ:RUN) CAO Michelle Philpot Sells 420 Shares

Sunrun Inc. (NASDAQ:RUN – Get Rating) CAO Michelle Philpot sold 420 shares of the business’s stock in a transaction that occurred on Monday, December 19th. The stock was sold at an average price of $27.70, for a total value of $11,634.00. Following the transaction, the chief accounting officer now owns 36,930 shares in the company, valued at $1,022,961. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Arcus Biosciences (NYSE:RCUS) Trading 9% Higher on Analyst Upgrade

Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating) traded up 9% during trading on Wednesday after Citigroup raised their price target on the stock from $37.00 to $42.00. Citigroup currently has a buy rating on the stock. Arcus Biosciences traded as high as $22.71 and last traded at $22.44. 23,287 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 934,108 shares. The stock had previously closed at $20.59.

Cinemark (NYSE:CNK) Stock Price Down 4.5% on Insider Selling

Cinemark Holdings, Inc. (NYSE:CNK – Get Rating)’s share price was down 4.5% during mid-day trading on Tuesday after an insider sold shares in the company. The company traded as low as $9.27 and last traded at $9.27. Approximately 62,325 shares changed hands during trading, a decline of 98% from the average daily volume of 2,733,993 shares. The stock had previously closed at $9.71.Specifically, Director Enrique Senior sold 35,054 shares of Cinemark stock in a transaction that occurred on Friday, December 9th. The stock was sold at an average price of $12.47, for a total value of $437,123.38. Following the sale, the director now directly owns 46,609 shares of the company’s stock, valued at $581,214.23. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 10.00% of the stock is currently owned by insiders.

error: Content is protected !!